Respiratory care year in review 2010: Part 1. asthma, COPD, pulmonary function testing, ventilator-associated pneumonia

Respiratory Care

Volumn 56, Issue 4, 2011, Pages 488-502

  Rubin, Bruce K ^a   Dhand, Rajiv ^b   Ruppel, Gregg L ^c   Branson, Richard D ^d   Hess, Dean R ^e  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

; Agonist; Asthma; Blocker; Copd; Corticosteroids; Exhaled nitric oxide; Oxygen therapy; Pulmonary function testing; Spirometry; Ventilator associated pneumonia; Vitamin d

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLARITHROMYCIN; CORTICOSTEROID; FLUTICASONE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MACROLIDE; MONTELUKAST; NITRIC OXIDE; PLACEBO; SALMETEROL; SIMVASTATIN; STEROID; TIOTROPIUM BROMIDE;

ACUTE DISEASE; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; COST OF ILLNESS; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; EMERGENCY CARE; ENDOTRACHEAL INTUBATION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; EXERCISE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HUMAN RHINOVIRUS; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; LUNG FUNCTION TEST; MEDICAL HISTORY; NONINVASIVE VENTILATION; OBESITY; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREDICTIVE VALUE; PROGNOSIS; RESPIRATORY CARE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK BENEFIT ANALYSIS; VENTILATOR ASSOCIATED PNEUMONIA; VITAMIN D DEFICIENCY;

ASTHMA; HUMANS; PNEUMONIA, VENTILATOR-ASSOCIATED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 79955646444     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01286     Document Type: Article

References (102)

1. Weiss ST. What genes tell us about the pathogenesis of asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(11):1170-1173.
2. Kabesch M, Michel S, Tost J. Epigenetic mechanisms and the relationship to childhood asthma. Eur Respir J 2010;36(4):950-961.
3. Lowe AJ, Carlin JB, Bennett CM, Hosking CS, Allen KJ, Robertson CF, et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ 2010;341:c4616.
4. Perzanowski MS, Miller RL, Tang D, Ali D, Garfinkel RS, Chew GL, et al. Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort. Thorax 2010;65(2): 118-123.
5. Voisin C, Sardella A, Marcucci F, Bernard A. Infant swimming in chlorinated pools and the risks of bronchiolitis, asthma and allergy. Eur Respir J 2010;36(1):41-47.
6. Cohen RT, Raby BA, Van Steen K, Fuhlbrigge AL, Celedńn JC, Rosner BA, et al; Childhood Asthma Management Program Research Group. In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma. J Allergy Clin Immunol 2010;126(3):491-497.
7. Mackay D, Haw S, Ayres JG, Fischbacher C, Pell JP. Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med 2010; 363(12):1139-1145.
8. Simões EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR; Palivizumab Long-Term Respiratory Outcomes Study Group. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010;126(2):256-262.
9. Bizzintino J, Lee WM, Laing IA, Vang F, Pappas T, Zhang G, et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2010;[Epub ahead of print]
10. Nagel G, Weinmayr G, Kleiner A, Garcia-Marcos L, Strachan DP; ISAAC Phase Two Study Group. Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC) Phase Two. Thorax 2010;65(6): 516-522.
11. Cottrell L, Neal WA, Ice C, Perez MK, Piedimonte G. Metabolic abnormalities in children with asthma. Am J Respir Crit Care Med 2010;[Epub ahead of print]
12. Hjellvik V, Tverdal A, Furu K. Body mass index as predictor for asthma: a cohort study of 118,723 males and females. Eur Respir J 2010;35(6):1235-1242.
13. Luks VP, Vandemheen KL, Aaron SD. Confirmation of asthma in an era of overdiagnosis. Eur Respir J 2010;36(2):255-260.
14. Pakhale S, Doucette S, Vandemheen K, Boulet LP, McIvor RA, Fitzgerald JM, et al. A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interaction. Chest 2010; 137(6):1316-1323.
15. Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DY. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol 2010;125(5):995-1000.
16. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. VitaminDlevels, lung function, and steroid responseinadult asthma. Am J Respir Crit Care Med 2010;181(7):699-704.
17. Mendes FA, Gonçalves RC, Nunes MP, Saraiva-Romanholo BM, Cukier A, Stelmach R, et al. Effects of aerobic training on psycho-social morbidity and symptoms in patients with asthma: a randomized clinical trial. Chest 2010;138(2):331-337.
18. Hewitt M, Estell K, Davis IC, Schwiebert LM. Repeated bouts of moderate-intensity aerobic exercise reduce airway reactivity in a murine asthma model. Am J Respir Cell Mol Biol 2010;42(2):243-249.
19. Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, Comhair SA, et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010;181(10):1033-1041.
20. Tseliou E, Bessa V, Hillas G, Delimpoura V, Papadaki G, Roussos C, et al. Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma. Chest 2010;138(1):107-113.
21. Debley JS, Stamey DC, Cochrane ES, Gama KL, Redding GJ. Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers. J Allergy Clin Immunol 2010;125(6):1228-1234.
22. Pérez-de-Llano LA, Carballada F, Castro Añón O, Pizarro M, Golpe R, Baloira A, et al. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. Eur Respir J 2010;35(6):1221-1227.
23. Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax 2010;65(1): 39-43.
24. Morris CR, Becker AB, Piñieiro A, Massaad R, Green SA, Smugar SS, Gurner DM. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma. Ann Allergy Asthma Immunol 2010;104(2):161-171.
25. Camargo CA Jr, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010;125(2):374-380.
26. Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ame-redes BUT, Boushey HA, et al; National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363(18):1715-1726.
27. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax 2010;65(10):891-896.
28. Sutherland ER, King TS, Icitovic N, Ameredes BT, Bleecker E, Boushey HA, et al; National Heart, Lung, and Blood Institute Asthma Clinical Research Network. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 2010;126(4):747-753.
29. Lemanske RF Jr, Mauger DT, Sorkness CA, Jackson DJ, Boehmer SJ, Martinez FD, et al; Childhood Asthma Research and Education (CARE) Network of the National Heart, Lung, and Blood Institute. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010; 362(11):975-985.
30. Thomas B, Rutman A, Hirst RA, Haldar P, Wardlaw AJ, Bankart J, et al. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J Allergy Clin Immunol 2010;126(4):722-729.
31. Deshpande DA, Wang WC, McIlmoyle EL, Robinett KS, Schil-linger RM, An SS, et al. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 2010;16(11):1299-1304.
32. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370(9589):765-773.
33. Martinez FD. The origins of asthma and chronic obstructive pulmonary disease in early life. Proc Am Thorac Soc 2009;6(3):272-277.
34. Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010;65(1):14-20.
35. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357(3):266-281.
36. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ. Prevalence of Vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7(5):439-443.
37. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005;16(7):713-716.
38. Black PN, Scragg R. Relationship between serum 25-hydroxyvita-min D and pulmonary function in the third national health and nutrition examination survey. Chest 2005;128(6):3792-3798.
39. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buys-schaert I, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the Vitamin D-binding gene. Thorax 2010;65(3):215-220.
40. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107(11):1514-1519.
41. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313(7059):711-716.
42. Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al; AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease 2006 update: endorsed by the National Heart, Lung and Blood Institute. Circulation 2006;113(19):2363-2372. Erratum in: Circulation 2006; 113(22):e847.
43. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al; American College of Cardiology Foundation; American Heart Association. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Car- diol 2009;53(15):e1-e90. Erratum in: J Am Coll Cardiol 2009; 54(25):2464.
44. Egred M, Shaw S, Mohammad B, Waitt P, Rodrigues E. Under-use of beta-blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease. QJM 2005;98(7): 493-497.
45. Rutten FH, Zuithoff NP, Hak E, Grobbee DE, Hoes AW. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch Intern Med 2010; 170(10):880-887.
46. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154(2 Pt 1):407-412.
47. Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999;340(25):1941-1947.
48. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Executive summary, updated 2009. http://www.goldcopd.org/guidelineitem.asp?l1=2&l2=1&intid;=2180. Accessed February 4, 2011.
49. National Collaborating Center for Chronic Conditions. Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):1-232.
50. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946.
51. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Roth-berg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 2010;303(23):2359-2367.
52. Sassoon CS, Hassell KT, Mahutte CK. Hyperoxic-induced hyper-capnia in stable chronic obstructive pulmonary disease. Am Rev Respir Dis 1987;135(4):907-911.
53. Robinson TD, Freiberg DB, Regnis JA, Young IH. The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161(5): 1524-1529.
54. Denniston AK, O'Brien C, Stableforth D. The use of oxygen in acute exacerbations of chronic obstructive pulmonary disease: a prospective audit of pre-hospital and hospital emergency management. Clin Med 2002;2(5):449-451.
55. Plant PK, Owen JL, Elliott MW. One year period prevalence study of respiratory acidosis in acute exacerbations of COPD; implications for the provision of non-invasive ventilation and oxygen administration. Thorax 2000;55(7):550-554.
56. Wijesinghe M, Perrin K, Healy B, Hart K, Clay J, Weatherall M, Beasley R. Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J 2010;[Epub ahead of print]
57. Austin MA, Willis KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomized controlled trial. BMJ 2010;341:c5462 DOI:10.1136/bmjc5462.
58. Almagro P, Salvado M, Garcia-Vidal C, Rodriguez-Carballeira M, Delgado M, Barreiro B, et al. Recent improvement in long-term survival after a COPD hospitalization. Thorax 2010;65(4):298-302.
59. Borg BM, Hartley MF, Fisher MT, Thompson BR. Spirometry training does not guarantee valid results. Respir Care 2010;55(6): 689-694.
60. Masa JF, Gonza ́lez MT, Pereira R, Mota M, Riesco JA, Corral J, et al. Validity of spirometry performed on-line. Eur Respir J 2010; [Epub ahead of print]
61. O'Donnell CR, Bankier AA, Stiebellehner L, Reilly JJ, Brown R, Loring SH. Comparison of plethysmographic and helium dilution lung volumes: which is best in COPD? Chest 2010;137(5):1108-1115.
62. Stanojevic S, Wade A, Cole TJ, Lum S, Custovic A, Silverman M, et al; Asthma UK Spirometry Collaborative Group. Spirometry centile charts for young Caucasian children: the Asthma UK Collaborative Initiative. Am J Respir Crit Care Med 2009;180(6):547-552.
63. Quanjer PH, Stocks J, Cole TJ, Hall GL, Stanojevic S; ERS Global Lungs Task Force. Influence of secular trends and sample size on reference equations for lung function tests. Eur Respir J 2010;[Epub ahead of print]
64. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-recommended reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study. Chest 2010;137(1): 138-145.
65. Miller MR, Pedersen OF. New concepts for expressing forced expiratory volume in 1 s arising from survival analysis. Eur Respir J 2010;35(4):873-882.
66. Quanjer PH, Stanojevic S, Stocks J, Hall GL, Prasad KV, Cole TJ, et al. Global Lungs Initiative. Changes in the FEV1/FVC ratio during childhood and adolescence: an intercontinental study. Eur Respir J 2010;36(6):1391-1399.
67. Hansen JE, Sun XG, Wasserman K. Calculating gambling odds and lung age for smokers. Eur Respir J 2010;35(4):776-780.
68. Newbury W, Newbury J, Briggs N, Crockett A. Exploring the need to update lung age equations. Prim Care Respir J 2010;19(3):242-247.
69. Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting pulmonary function data using 80% predicted and fixed thresholds misclassifies over 20% of patients. Chest 2011;139(1): 52-59.
70. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM. The ratio of FEV1/FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(5):446-451.
71. Quanjer PH, Enright PL, Ruppel GL. The GOLD guidelines definition of mild airway obstruction (letter). Respir Care 2010;55(10): 1397-1398.
72. Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Marg-olis BD, et al; NASCENT Investigation Group. Silver-coated en-dotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008;300(7):805-813.
73. Rello J, Afessa B, Anzueto A, Arroliga AC, Olson ME, Restrepo MI, et al. Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extu-bation. Crit Care Med 2010;38(4):1135-1140.
74. Afessa B, Shorr AF, Anzueto AR, Craven DE, Schinner R, Kollef MH. Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest 2010;137(5):1015-1021.
75. Neiderman MS. Fighting vampires and ventilator-associated pneumonia: is silver the magic bullet? Chest 2010;137(5):1007-1009.
76. Palmore TN, Henderson DK. Testing the tube: assessing silver as a potential "silver bullet" for preventing ventilator-associated pneumonia. Crit Care Med 2010;38(4):1220-1221.
77. Deem S, Treggiari MM. New endotracheal tubes designed to prevent ventilator-associated pneumonia: do they make a difference? Respir Care 2010;55(8):1046-1055.
78. Gentile MA, Siobal MS. Are specialized endotracheal tubes and heat-and-moisture exchangers cost-effective in preventing ventilator associated pneumonia? Respir Care 2010;55(2):184-196.
79. Lacherade JC, De Jonghe B, Guezennec P, Debbat K, Hayon J, Monsel A, et al. Intermittent subglottic secretion drainage and ventilator-associated pneumonia: a multicenter trial. Am J Respir Crit Care Med 2010;182(7):910-917.
80. Terragni PP, Antonelli M, Fumagalli R, Faggiano C, Beradino M, Pallavicini FB, et al. Early vs. late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA 2010;303(15):1483-1489.
81. Durbin CG Jr, Perkins MP, Moores LK. Should tracheostomy be performed as early as 72 hours in patients requiring prolonged mechanical ventilation? Respir Care 2010;55(1):76-87.
82. Pitts R, Fisher D, Sulemanji D, Kratohvil J, Jiang Y, Kacmarek R. Variables affecting leakage past endotracheal tube cuffs: a bench study. Intensive Care Med 2010;36(12):2066-2073.
83. Zanella A, Scaravilli V, Isgró S, Milan M, Cressoni M, Patroniti N, et al. Fluid leakage across tracheal tube cuff, effect of different cuff material, shape, and positive expiratory pressure: a bench-top study. Intensive Care Med 2010;[Epub ahead of print]
84. Dave MH, Frotzler A, Spielmann N, Madjdpour C, Weiss M. Effect of tracheal tube cuff shape on fluid leakage across the cuff: an in vitro study. Br J Anaesth 2010;105(4):538-543.
85. Dave MH, Koepfer N, Madjdpour C, Frotzler A, Weiss M. Tracheal fluid leakage in benchtop trials: comparison of static versus dynamic ventilation model with and without lubrication. J Anesth 2010;24(2):247-252.
86. Burns KE, Adhikari NK, Keenan SP, Meade MO. Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev 2010; (8):CD004127.
87. Kohlenberg A, Schwab F, Behnke M, Geffers C, Gastmeier P. Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database. Intensive Care Med 2010;36(6):971-978.
88. Maxwell RA, Green JM, Waldrop J, Dart BW, Smith PW, Brooks D, et al. A randomized prospective trial of airway pressure release ventilation and low tidal volume ventilation in adult trauma patients with acute respiratory failure. J Trauma 2010;69(3):501-510.
89. Rello J, Chastre J, Cornaglia G, Masterton R; VAP Care Bundles Contributors. A European care bundle for management of ventilator-associated pneumonia. J Crit Care 2010;[Epub ahead of print].
90. Miller RS, Norris PR Jenkins JM, Talbot TR III, Starmer JM, Hutchison SA, et al. Systems initiatives reduce healthcare-associated infections: a study of 22,928 device days in a single trauma unit. J Trauma 2010;68(1):23-31.
91. Bouadma L, Deslandes E, Lolom I, Le Corre B, Mourvillier B, Regnier B, et al. Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis 2010;51(10):1115-1122.
92. Magret M, Amaya-Villar R, Garnacho J, Lisboa T, Díaz E, Dew-aele J, etal; EU-VAP/CAP Study Group. Ventilator-associated pneumonia in trauma patients is associated with lower mortality: results from EU-VAP study. J Trauma 2010;69(4):849-854.
93. Restrepo MI, Anzueto A, Arroliga AC, Afessa B, Atkinson MJ, Ho NJ, etal. Economic burdenofventilator-associated pneumonia based on total resource utilization. Infect Control Hosp Epidemiol 2010; 31(5):509-515.
94. Czosnowski QA, Wood GC, Magnotti LJ, Croce MA, Swanson JM, Boucher BA, Fabian TC. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia. Pharmacotherapy 2009;29(9):1054-1060.
95. Mounier R, Adrie C, Français A, Garrouste-Orgeas M, Cheval C, Allaouchiche B, et al; OUTCOMEREA Study Group. Study of prone positioning to reduce ventilator-associated pneumonia in hy-poxaemic patients. Eur Respir J 2010;35(4):795-804.
96. Staudinger T, Bojic A, Holzinger U, Meyer B, Rohwer M, Maliner F, et al. Continuous lateral rotation therapy to prevent ventilator-associated pneumonia. Crit Care Med 2010;38(2):486-490.
97. Mauri T, Berra L, Kumwilaisak K, Pivi S, Ufberg JW, Kueppers F, et al. Lateral-horizontal patient position and horizontal orientation of the endotracheal tube to prevent aspiration in adult surgical intensive care unit patients: a feasibility study. Respir Care 2010; 55(3):294-302.
98. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia:ablinded, randomized, controlled trial. Am J Respir Crit Care Med 2010;182(8):1058-1064.
99. Barraud D, Blard C, Hein F, Marçon O, Cravoisy A, Nace L, et al. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 2010;36(9):1540-1547.
100. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled. Crit Care Med 2010; 38(3):954-962.
101. Han J, Liu Y. Effect of ventilator circuit changes on ventilator-associated pneumonia: a systematic review and meta-analysis. Re-spir Care 2010;55(4):467-474.
102. Samransamruajkit R, Jirapaiboonsuk S, Siritantiwat S, Tungsrijit-dee O, Deerojanawong J, Sritippayawan S, Prapphal N. Effect of frequency of ventilator circuit changes (3 vs 7 days) on the rate of ventilator-associated pneumonia in PICU. J Crit Care 2010;25(1): 56-61.